Start with traceability, not the purity number
A certificate of analysis is a record of reported tests and results for an identified material. It is not self-authenticating. Before interpreting a chromatogram or a percentage, confirm that the document can be connected to the exact lot being offered.
For formal active-ingredient records, FDA guidance describes COA fields such as the material name, grade, batch or lot number, release date, tests, acceptance limits, and numerical results. Research-supplier documents vary, but those fields remain a useful baseline for evaluating completeness.
- Material name and stated form
- Batch or lot identifier
- Test and report dates
- Named laboratory and report identifier
- Methods, specifications, and numerical results
Separate the claim from the evidence
A polished PDF can still be incomplete. Look for a report number, analyst or approval information, instrument output, and enough method context to understand what was measured. Confirm that the lot shown on the report matches the lot a supplier says it is selling.
A report hosted only as a generic product-page image, with no lot match or testing date, provides weaker traceability than a batch-specific document.
Know what a COA does not establish
An HPLC area percentage does not, by itself, establish molecular identity, peptide content by mass, sterility, endotoxin status, residual solvents, stability, or suitability for a particular protocol. Each of those questions requires appropriate evidence and methods.
Treat the COA as one part of supplier qualification. Even regulated supply chains periodically verify the reliability of supplier certificates rather than relying on the document forever.
Read the identity evidence separately
Identity asks whether the material contains the molecule it is represented to contain. Purity asks about the relative amount of detected components under a defined procedure. A report should not use a chromatographic area percentage as a substitute for identity evidence.
Mass spectrometry can support identity when the expected and observed ions are reported coherently. Stronger documentation also identifies the sample, method, instrument, expected result, observed result, and reviewer—not merely a cropped spectrum.
Check whether quantity was actually measured
A vial label may state a nominal amount, while the COA reports only chromatographic purity. Those are different claims. Confirm whether the laboratory performed a quantitative assay, what reference or calibration approach was used, and whether the reported result refers to peptide content, total filled mass, or another measurement.
Without a suitable quantitative method, a high purity percentage cannot verify that the container holds the labeled amount.
Use a repeatable COA checklist
Record the page URL, access date, lot number, report number, laboratory, methods, and unresolved questions. Then preserve a copy of the document because supplier pages and linked files can change.
A useful conclusion is bounded: state what the report supports, what it does not address, and which connections you could independently verify.
- Does the product lot match the report?
- Are identity and purity supported by appropriate, distinct evidence?
- Is the laboratory verifiable and is the full report available?
- Are test dates, methods, specifications, and results visible?
- Are quantity, sterility, endotoxin, and stability claims supported when those claims are made?
Sources and further reading
Primary and standards-based sources used to frame this educational overview:
Peptide Due Diligence Research Brief
Keep the evidence in view.
Receive concise briefings on analytical testing, documentation quality, supplier transparency, and new additions to the research library.
By subscribing, you agree to receive PDD research emails. Unsubscribe at any time.
Already subscribed? Get your free checklist.